UNH Stock Risk & Deep Value Analysis
UnitedHealth Group Inc
Healthcare • Healthcare Plans
DVR Score
out of 10
What You Need to Know About UNH Stock
We analyzed UnitedHealth Group Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran UNH through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Moderate-High. Here's what we found.
UNH Risk Analysis & Red Flags
What Could Go Wrong
The Optum Health segment, previously a key growth engine, could continue to experience operational losses and fail to recover quickly, becoming a drag on overall profitability. Concurrently, severe regulatory pressure on Medicare Advantage rates or unfavorable outcomes from the DOJ probe could significantly restrict revenue and margin expansion in its core insurance business, leading to sustained underperformance.
Risk Matrix
Overall
Moderate-High
Financial
Low
Market
Low
Competitive
Medium
Execution
Medium
Regulatory
High
Red Flags
- ⚠
Optum Health segment reported an operating loss of $278M in FY2025, a sharp decline from $7.77B income in FY2024.
- ⚠
CMS proposed a 0.09% Medicare Advantage rate increase for 2027, significantly below industry expectations (e.g., 6%).
- ⚠
Ongoing DOJ probe introduces regulatory uncertainty and potential legal ramifications.
- ⚠
Anticipated membership decline of >3M in 2026 due to exiting underpriced MA/Medicaid markets.
Upcoming Risk Events
- 📅
Unfavorable outcome or penalties from ongoing DOJ probe
- 📅
Further negative trends or additional losses in Optum Health
- 📅
Deterioration of medical care ratio in 2026
- 📅
More restrictive government policies on healthcare pricing or insurance models
When to Reconsider
- 🚪
If Optum Health reports consecutive quarters of operating losses or significant revenue decline.
- 🚪
If 2027 Medicare Advantage rate finalization is materially worse than the already low 0.09% proposal.
- 🚪
Any substantial negative development or penalties from the DOJ investigation.
Unlock UNH Risk Analysis & Red Flags
Create a free account to see the full analysis
What Does UnitedHealth Group Inc (UNH) Do?
Market Cap
$276.23B
Sector
Healthcare
Industry
Healthcare Plans
Employees
400,000
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older; Medicaid plans, children's health insurance and health care programs; and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
Visit UnitedHealth Group Inc WebsiteInvestment Thesis
UnitedHealth Group is a foundational holding in the healthcare sector, offering stable revenue growth, consistent profitability (despite recent Optum challenges), and strong cash flow generation, driven by its dual engines of UnitedHealthcare and Optum. While its mega-cap status and regulatory headwinds preclude 10x growth potential, it remains a robust choice for long-term portfolio stability and dividend income, benefiting from underlying demographic tailwinds in healthcare demand.
Is UNH Stock Undervalued?
Unlock the full AI analysis for UNH
Get the complete DVR score, risk analysis, and more
Unlock the full report
Create a free account to see the DVR score, risk flags, and AI analysis.
UNH Price Targets & Strategy
12-Month Target
$330.00
Bull Case
$355.00
Bear Case
$270.00
Valuation Basis
Based on 18.6x P/E (current multiple using FY25 EPS) applied to FY26 adjusted EPS guidance of >$17.75.
Entry Strategy
For long-term holders seeking stable returns, consider dollar-cost averaging on dips towards $290-$300. The 200-day SMA is likely above this given recent price increases, but these levels represent reasonable support points.
Exit Strategy
Given the limited 10x potential, profit-taking for short-term gains could be considered near the $330-$340 range. A stop-loss around $285 could manage downside risk, especially if Optum news worsens or regulatory pressures intensify.
Portfolio Allocation
2-4% for conservative to moderate risk tolerance, focusing on stability and healthcare exposure rather than aggressive growth.
Price Targets & Strategy
Upgrade to Premium for price targets and entry/exit strategies
Is UNH Financially Healthy?
Valuation
P/E Ratio
22.91
Forward P/E
9.35
PEG Ratio
1.40
Profitability
Operating Margin
4.18%
Net Margin
2.69%
Return on Equity
12.50%
Revenue Growth
1181.00%
EPS
$13.19
Balance Sheet
Current Ratio
0.88
Quick Ratio
0.67
Debt/Equity
0.01
Other
Beta (Volatility)
0.42
Dividend Yield
2.90%
Does UNH Have a Competitive Moat?
Sign in to unlockMoat Rating
🏰 Wide
Moat Trend
Stable, but facing regulatory erosion in certain segments.
Moat Sources
4 Identified
UNH's moat is highly durable due to its immense scale in insurance and healthcare services, which provides significant cost advantages and network effects. The complexity of its offerings creates high switching costs for large clients. Its vast data infrastructure and brand equity further solidify its position, ensuring persistence for decades, although regulatory actions can always chip away at profitability.
Moat Erosion Risks
- •Increased government intervention or stricter regulations (e.g., further Medicare Advantage rate cuts, anti-trust actions).
- •Disruption from new healthcare delivery models or technology companies gaining significant market share.
- •Intensified competition leading to price compression or loss of key contracts, particularly if Optum's struggles persist.
UNH Competitive Moat Analysis
Sign up to see competitive advantages
UNH Market Intelligence
Sentiment & Insider Activity
Social Sentiment
Neutral (Large-cap healthcare stocks rarely generate significant retail social media buzz; focus is on stability and dividends rather than speculative growth).
Institutional Sentiment
Neutral/Slightly Positive (Raymond James upgrade to Outperform, but the negative news regarding Optum and MA rates might temper broader institutional enthusiasm, preventing a strong 'Positive' rating).
Insider Activity (Form 4)
Director Michele J. Hooper acquired 206 deferred stock units (compensation grant) on April 1, 2026. No open market buys/sells by CEO/CFO or other significant insider transactions reported in the last 90 days, indicating routine compensation rather than high-conviction open-market activity.
Options Flow
Normal options activity (For a company of UNH's size and maturity, significant unusual options activity is less common unless a major event is imminent. No specific data provided in the research suggests otherwise).
Earnings Intelligence
Next Earnings
2026-04-21
Surprise Probability
Medium
Historical Earnings Pattern
Historically, UNH often provides steady, predictable earnings reports due to its scale. While minor beats or misses can occur, the stock tends to react with moderate movements unless there are significant changes to forward guidance or unexpected segment performance, like the recent Optum Health loss.
Key Metrics to Watch
Competitive Position
Top Competitor
CVS Health (Aetna) or Elevance Health (Anthem)
Market Share Trend
Stable in core insurance markets, but facing pressure in Medicare Advantage/Medicaid with anticipated membership decline. Optum Rx is gaining new relationships, suggesting market share gains in PBM services.
Valuation vs Peers
UNH typically trades at a slight premium to some pure-play health insurers due to its diversified Optum segment and consistent growth, but it's generally in line with large, stable healthcare conglomerates on metrics like P/E and EV/EBITDA. The recent Optum performance could pressure this premium.
Competitive Advantages
- •Unparalleled scale and extensive market reach in both insurance and healthcare services.
- •Integrated Optum platform (though currently challenged) offers synergistic advantages in care delivery and pharmacy benefits.
- •Vast data analytics capabilities for cost management and personalized care.
- •Strong brand recognition and established relationships with providers and employers.
Market Intelligence
Get sentiment, earnings intel, and peer analysis with Premium
What Could Drive UNH Stock Higher?
Near-Term (0-6 months)
- •Q1 2026 Earnings Report (April 21, 2026)
- •Updates on Optum Health's restructuring progress
Medium-Term (6-18 months)
- •Finalization of 2027 Medicare Advantage rates by CMS
- •Integration of new Optum Rx relationships scaling in 2026-2027
Long-Term (18+ months)
- •Continued demographic tailwinds for healthcare demand
- •Expansion of integrated care delivery models through Optum
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for UNH?
- ✓
Optum Health operating income returning to positive territory and demonstrating consistent growth.
- ✓
Favorable resolutions or clarity regarding the DOJ probe.
- ✓
Improvements in the Medicare Advantage regulatory environment and membership trends.
- ✓
Sustained organic revenue growth across both UnitedHealthcare and Optum segments.
Bull Case Analysis
See what could go right with Premium
Competing with UNH
See how UnitedHealth Group Inc compares to related companies
| Company | Market Cap | DVR Score | P/E | Revenue | Profit Margin | Rev Growth | |
|---|---|---|---|---|---|---|---|
UnitedHealth Group Inc UNH | $276.2B | 0.3 | 22.9 | $113.7B | 2.7% | 1181.0% | |
AbbVie Inc ABBV | $403.8B | 0.1 | 171.8 | — | — | — | Compare → |
Johnson & Johnson JNJ | — | 1.0 | — | — | — | — | Compare → |
Eli Lilly and Co LLY | $965.0B | 0.5 | 52.6 | — | — | — | Compare → |
Pfizer Inc PFE | $150.6B | 0.2 | 19.4 | $62.6B | 12.4% | -1.6% | Compare → |
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
How UnitedHealth Group Inc Makes Money
UnitedHealth Group is a diversified healthcare company that primarily makes money through two main segments: UnitedHealthcare and Optum. UnitedHealthcare acts as a health insurer, collecting premiums from individuals, employers, and government programs (like Medicare and Medicaid) in exchange for covering medical costs. Optum, on the other hand, provides a wide array of health services, including pharmacy benefits management (Optum Rx), healthcare delivery (Optum Health), and technology/consulting services (Optum Insight), earning fees for these services. Essentially, they generate revenue by managing and providing healthcare benefits and services across the entire healthcare ecosystem.
Read Full Business Model BreakdownFAQ
What is the DVR Score for UnitedHealth Group Inc (UNH)?
As of April 13, 2026, UnitedHealth Group Inc has a DVR Score of 0.3 out of 10, placing it in the "Distressed" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.
What is the market capitalization of UnitedHealth Group Inc?
UnitedHealth Group Inc's market capitalization is approximately $276.2B. The company operates in the Healthcare sector within the Healthcare Plans industry.
What ticker symbol does UnitedHealth Group Inc use?
UNH is the ticker symbol for UnitedHealth Group Inc. The company trades on the NYQ.
What is the risk level for UNH stock?
Our analysis rates UnitedHealth Group Inc's overall risk as Moderate-High. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.
What is the P/E ratio of UNH?
UnitedHealth Group Inc currently has a price-to-earnings (P/E) ratio of 22.9. This is in line with broader market averages.
Does UnitedHealth Group Inc pay a dividend?
Yes, UnitedHealth Group Inc pays a dividend with a current yield of approximately 2.90%.
Is UnitedHealth Group Inc's revenue growing?
UnitedHealth Group Inc has reported revenue growth of 1181.0%. The company is showing strong top-line momentum.
Is UNH stock profitable?
UnitedHealth Group Inc has a profit margin of 2.7%. The company is profitable but margins are modest.
How often is the UNH DVR analysis updated?
Our AI-powered analysis of UnitedHealth Group Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on April 13, 2026.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for UNH (UnitedHealth Group Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.